drugset / Trial / NCT01148745

Iron Indices and Intravenous Ferumoxytol: Time to Steady State

NCT01148745

Phase 4 Completed 15 enrolled Dialysis Clinic, Inc.
NaSingle-groupOpen-labelBasic science

Summary

The purpose of this study is to evaluate the time point of transferrin saturation (TSAT) and ferritin stabilization after a thirteen-treatment period following a ferumoxytol load, as well as to determine the point at which serum ferritin and TSAT concentrations can be checked in iron deficiency anemia (IDA) hemodialysis patients.

Timeline

Start
2010-03
Primary completion
2010-04
Completion
2010-05

Drugs

EvaluationDrugModalityDoseRoute
Subject Ferumoxytol Diagnostic / imaging agent 510 mg Intravenous